This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Beijing Jitai Life Sciences Ltd., Metis Techbio Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2026
Title: Moyan Liu: Innovator in Lipid Compounds
Introduction
Moyan Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of rapidly metabolized lipid compounds. His innovative work has the potential to impact drug delivery systems and enhance therapeutic efficacy.
Latest Patents
Moyan Liu holds a patent for a class of rapidly metabolized lipid compounds. This patent, which includes 1 patent, specifically relates to compounds represented by a certain formula, along with their pharmaceutically acceptable salts, isotopic variants, tautomers, or stereoisomers. Additionally, the patent covers a nanoparticle pharmaceutical composition that incorporates these compounds, emphasizing their application in the delivery of nucleic acids.
Career Highlights
Throughout his career, Moyan Liu has worked with notable companies such as Beijing Jitai Life Sciences Ltd. and Metis Techbio Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in lipid compounds.
Collaborations
Moyan Liu has collaborated with talented individuals such as Lin Zhang and Feng Shi. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Moyan Liu is a distinguished inventor whose work in rapidly metabolized lipid compounds showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions are poised to make a significant impact in the field of drug delivery.